schliessen

Filtern

 

Bibliotheken

1.

Paying a high price for cancer drugs
by The Lancet

Lancet (London, England), 01 August 2015, Vol.386(9992), pp.404

6.

Exposure to anticancer drugs can result in transgenerational genomic instability in mice.
by Glen, Colin D

Proceedings of the National Academy of Sciences of the United States of America, February 21, 2012, Vol.109(8), pp.2984-2988

12.

A multiply convergent platform for the synthesis of trioxacarcins.
by Švenda, Jakub

Proceedings of the National Academy of Sciences of the United States of America, April 26, 2011, Vol.108(17), pp.6709-6714

14.

In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction.
by Shima, Fumi

Proceedings of the National Academy of Sciences of the United States of America, May 14, 2013, Vol.110(20), pp.8182-8187

16.

Foretinib is a potent inhibitor of oncogenic ROS1 fusion proteins.(MEDICAL SCIENCES)(Report)(Author abstract)
by Davare, Monika A.

Proceedings of the National Academy of Sciences of the United States, Nov 26, 2013, Vol.110(48), p.19519(6)

17.

Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile.
by Park, Ga Young

Proceedings of the National Academy of Sciences of the United States of America, July 24, 2012, Vol.109(30), pp.11987-11992

Recommended databases

Find more Articles matching your search terms in these recommended databases.

Filter electronic articles 101.322 Hits

Remove Filters